Sampling constraints, sparse-cell estimates, and cross-sectional inference: considerations on hr-HPV prevalence and associated factors among HIV-positive women in Mekelle, Ethiopia.
{"title":"Sampling constraints, sparse-cell estimates, and cross-sectional inference: considerations on hr-HPV prevalence and associated factors among HIV-positive women in Mekelle, Ethiopia.","authors":"Shweta Thusoo","doi":"10.1186/s13027-026-00801-3","DOIUrl":null,"url":null,"abstract":"<p><p>Shfare et al. report a high-risk human papillomavirus (hr-HPV) prevalence of 39.7% among HIV-positive women attending public health facilities in Mekelle, Ethiopia, and identify several clinical and behavioural predictors using multivariable logistic regression. The study addresses an important evidence gap in a high-burden setting and employs rigorous molecular detection methods. Nevertheless, three methodological considerations affect the interpretation of the findings. First, facility-based recruitment from selected antiretroviral therapy (ART) clinics may limit the generalizability of the reported prevalence estimate and observed associations to the broader population of women living with HIV. Second, several adjusted odds ratios are accompanied by wide confidence intervals, indicating limited precision and warranting cautious interpretation. Finally, the cross-sectional design precludes causal inference regarding the association between oral contraceptive use and hr-HPV infection because residual confounding and reverse causation cannot be excluded. Collectively, these issues suggest that the findings should be interpreted cautiously and highlight the need for prospective population-based studies to validate the reported risk factors before they inform screening or prevention strategies.</p>","PeriodicalId":13568,"journal":{"name":"Infectious Agents and Cancer","volume":"21 1","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13617853/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Agents and Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13027-026-00801-3","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Shfare et al. report a high-risk human papillomavirus (hr-HPV) prevalence of 39.7% among HIV-positive women attending public health facilities in Mekelle, Ethiopia, and identify several clinical and behavioural predictors using multivariable logistic regression. The study addresses an important evidence gap in a high-burden setting and employs rigorous molecular detection methods. Nevertheless, three methodological considerations affect the interpretation of the findings. First, facility-based recruitment from selected antiretroviral therapy (ART) clinics may limit the generalizability of the reported prevalence estimate and observed associations to the broader population of women living with HIV. Second, several adjusted odds ratios are accompanied by wide confidence intervals, indicating limited precision and warranting cautious interpretation. Finally, the cross-sectional design precludes causal inference regarding the association between oral contraceptive use and hr-HPV infection because residual confounding and reverse causation cannot be excluded. Collectively, these issues suggest that the findings should be interpreted cautiously and highlight the need for prospective population-based studies to validate the reported risk factors before they inform screening or prevention strategies.
期刊介绍:
Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer.
The journal welcomes submissions in the pathogen-related cancer areas and other related topics, in particular:
• HPV and anogenital cancers, as well as head and neck cancers;
• EBV and Burkitt lymphoma;
• HCV/HBV and hepatocellular carcinoma as well as lymphoproliferative diseases;
• HHV8 and Kaposi sarcoma;
• HTLV and leukemia;
• Cancers in Low- and Middle-income countries.
The link between infection and cancer has become well established over the past 50 years, and infection-associated cancer contribute up to 16% of cancers in developed countries and 33% in less developed countries.
Preventive vaccines have been developed for only two cancer-causing viruses, highlighting both the opportunity to prevent infection-associated cancers by vaccination and the gaps that remain before vaccines can be developed for other cancer-causing agents. These gaps are due to incomplete understanding of the basic biology, natural history, epidemiology of many of the pathogens that cause cancer, the mechanisms they exploit to cause cancer, and how to interrupt progression to cancer in human populations. Early diagnosis or identification of lesions at high risk of progression represent the current most critical research area of the field supported by recent advances in genomics and proteomics technologies.